Amoxicillin 500 Mg
Amoxicillin 500 Mg is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Controlled Human Pneumococcal Infection Model (PIM) Study
Antibiotic and Probiotic Therapies in the Adjuvant Treatment of the Chronic Periodontitis.
Preoperative Dose of Co-amoxiclav for Prevention of Postoperative Complications in Dentoalveolar Surgery
Prevention of Dry Socket by Means of Single Preoperative Antibiotics Compared to Conventional Therapy
Complications After Lower Third Molar Surgery
Clinical Trials (7)
A Controlled Human Pneumococcal Infection Model (PIM) Study
Antibiotic and Probiotic Therapies in the Adjuvant Treatment of the Chronic Periodontitis.
Preoperative Dose of Co-amoxiclav for Prevention of Postoperative Complications in Dentoalveolar Surgery
Prevention of Dry Socket by Means of Single Preoperative Antibiotics Compared to Conventional Therapy
Complications After Lower Third Molar Surgery
10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7